Teva Pharmaceutical Industries Ltd. ADR represents shares of an Israeli-based global pharmaceutical company focused on developing, manufacturing, and marketing medicines across multiple therapeutic areas. Teva is widely recognized for its large portfolio of generic drugs, which provide cost-effective alternatives to branded treatments and support healthcare systems in controlling medication expenditure. Alongside generics, Teva offers specialty and biopharmaceutical products in fields such as central nervous system disorders, respiratory conditions, oncology, and other chronic diseases. The company serves hospitals, pharmacies, healthcare providers, and wholesalers across North America, Europe, and a broad range of international markets through regionally organized business segments. Teva also engages in the sale of active pharmaceutical ingredients and provides contract manufacturing services, reinforcing its role in the wider pharmaceutical supply chain. Founded in 1901 and headquartered in Tel Aviv, Israel, Teva Pharmaceutical Industries Ltd. ADR gives investors exposure to one of the world’s leading players in generic and branded pharmaceutical products.